Geisel Receives $12.5 Million NIH COBRE Renewal Grant Supporting Institute for Biomolecular Targeting at Dartmouth

The bioMT project is funded as an Institutional Development Award (IDeA) Center for Biomedical Research Excellence (COBRE) from the NIH's National Institute of General Medical Sciences. The IDeA program builds research capacity in states that historically have had low levels of NIH funding—by supporting basic, clinical, and translational research; faculty development; and infrastructure improvements.

"The COBRE grants provide support in three 5-year phases, which can be thought of as 'building, strengthening, and transitioning' stages in funding," explains Dean Madden, PhD, a professor of biochemistry and cell biology at Geisel, who serves as director of bioMT and principal investigator of the COBRE grant, as well as the vice provost for research at Dartmouth. "Success at each phase helps to ensure continued support in the next, with the long-term goal of centers becoming fully self-supporting."

Read the full article.